Induction of Apoptosis by (Z)-Stellettic Acid C, an Acetylenic Acid from the Sponge Stelletta sp., Is Associated with Inhibition of Telomerase Activity in Human Leukemic U937 Cells

Background: (Z)-Stellettic acid C, an acetylenic acid from the marine sponge Stelletta sp., has been shown to have cytotoxic activity in some cancer cells; however, its mechanisms on malignant cell growth are not known. In this study, the potential of (Z)-stellettic acid C to induce apoptosis in human leukemic U937 cells and its effects on telomerase activity were investigated. Methods: Cytotoxicity was evaluated by MTT assays. Apoptosis was detected using DAPI staining and annexin V fluorescein. The mRNAs of Bcl-2, inhibitor of apoptosis proteins (IAPs) family and Fas/FasL system were determined by RT-PCR. Caspases and telomerase activities were measured using colorimetric assay and telomeric repeat amplification protocol enzyme-linked immunosorbent assay (TRAP-ELISA), respectively. Results: Exposure of U937 cells to (Z)-stellettic acid C resulted in growth inhibition and induction of apoptosis in a dose-dependent manner, which was associated with the modulation of Bcl-2 family expression, activation of caspases and downregulation of IAPs family members. (Z)-Stellettic acid C treatment markedly inhibited the activity of telomerase in a dose-dependent fashion. Additionally, the expression of human telomerase reverse transcriptase, a main determinant of the telomerase enzymatic activity, was progressively downregulated by (Z)-stellettic acid C treatment. Conclusions: These results suggest that (Z)-stellettic acid C could have a possible cancer therapeutic potential.

[1]  R. Lempicki,et al.  Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. , 2005, Experimental and molecular pathology.

[2]  Yung-Hyun Choi,et al.  Induction of apoptosis by dideoxypetrosynol A, a polyacetylene from the sponge Petrosia sp., in human skin melanoma cells. , 2004, International journal of molecular medicine.

[3]  G. Brumatti,et al.  Butyrate Increases Apoptosis Induced by Different Antineoplastic Drugs in Monocytic Leukemia Cells , 2004, Chemotherapy.

[4]  S. Fulda,et al.  Targeting apoptosis pathways in cancer therapy. , 2004, Current cancer drug targets.

[5]  David J Newman,et al.  Marine natural products and related compounds in clinical and advanced preclinical trials. , 2004, Journal of natural products.

[6]  E. Ulukaya,et al.  Interference by Anti-Cancer Chemotherapeutic Agents in the MTT-Tumor Chemosensitivity Assay , 2004, Chemotherapy.

[7]  Seng H. Cheng,et al.  Fas ligand gene therapy for vascular intimal hyperplasia. , 2004, Current gene therapy.

[8]  S. Gerson,et al.  Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy. , 2003, Trends in pharmacological sciences.

[9]  K. Gustafson,et al.  Marine pharmacology in 2000: Antitumor and cytotoxic compounds , 2003, International journal of cancer.

[10]  Jongki Hong,et al.  New acetylenic acids from the marine sponge Stelletta species. , 2003, Journal of natural products.

[11]  G. Bifulco,et al.  Halipeptins A and B: two novel potent anti-inflammatory cyclic depsipeptides from the Vanuatu marine sponge Haliclona species. , 2001, Journal of the American Chemical Society.

[12]  F. Zindy,et al.  c-Myc-mediated Regulation of Telomerase Activity Is Disabled in Immortalized Cells* , 2001, The Journal of Biological Chemistry.

[13]  W. Hahn,et al.  Telomerase activation, cellular immortalization and cancer , 2001, Annals of medicine.

[14]  M. Hengartner The biochemistry of apoptosis , 2000, Nature.

[15]  M. Yutsudo,et al.  Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). , 2000, Nucleic acids research.

[16]  L. Harrington,et al.  Telomeres, telomerase, and cancer: life on the edge of genomic stability , 2000, Current opinion in oncology.

[17]  S. Kyo,et al.  Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors , 1999, International journal of cancer.

[18]  M. Mattson,et al.  Anti-apoptotic Role of Telomerase in Pheochromocytoma Cells* , 1999, The Journal of Biological Chemistry.

[19]  G. Salvesen,et al.  Properties of the caspases. , 1998, Biochimica et biophysica acta.

[20]  S. Kyo,et al.  Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. , 1998, Cancer research.

[21]  John Calvin Reed,et al.  The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.

[22]  M. Mandal,et al.  Bcl-2 Modulates Telomerase Activity* , 1997, The Journal of Biological Chemistry.

[23]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[24]  C. Potten,et al.  Apoptosis and cancer chemotherapy. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[25]  M. Kelly-Borges,et al.  Antifungal activity of meridine, a natural product from the marine sponge Corticium sp. , 1992, Journal of natural products.

[26]  S. Cory,et al.  Life-or-death decisions by the Bcl-2 protein family. , 2001, Trends in biochemical sciences.

[27]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[28]  G. Kroemer,et al.  Mitochondria in chemotherapy-induced apoptosis: a prospective novel target of cancer therapy (review). , 1998, International journal of oncology.